Increased serum ATX levels have been recently reported in severe COVID-19 patients, also correlating with the markers of endothelial dysfunction (sP-sel, sICAM) [10], further enforcing the correlation between ATX/LPA and endothelial damage [37]. This evidence concerns the gene ENPP2 and COVID-19.